quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:14:52·624d
SECFiling
Acasti Pharma Inc. logo

SEC Form 424B3 filed by Acasti Pharma Inc.

ACST· Acasti Pharma Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ACST
    Acasti Pharma Inc.
    Health Care

Recent analyst ratings

  • Dec 22UpdateOppenheimer$6.00
  • Dec 21UpdateOppenheimer$6.00

Related

  • PR472d
    Grace Therapeutics to Participate in Upcoming Investor Events January 2025
  • PR506d
    Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
  • SEC543d
    Acasti Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • SEC546d
    Acasti Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR546d
    Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
  • SEC555d
    SEC Form EFFECT filed by Acasti Pharma Inc.
  • SEC555d
    SEC Form EFFECT filed by Acasti Pharma Inc.
  • SEC563d
    SEC Form S-8 filed by Acasti Pharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022